| A comparison between a propensity weighted web survey and an identical RDD survey BS Schonlau M, Zapert K, Payne Simon L, Sanstad K, Marcus S, Adams J ... Social Science Computer Review 22 (1), 128-138, 2004 | 247* | 2004 |
| Incidence and US costs of corticosteroid-associated adverse events: a systematic literature review E Sarnes, L Crofford, M Watson, G Dennis, H Kan, D Bass Clinical therapeutics 33 (10), 1413-1432, 2011 | 246 | 2011 |
| Prevalence and the associated burden of illness of symptoms of diabetic peripheral neuropathy and diabetic retinopathy SD Candrilli, KL Davis, HJ Kan, MA Lucero, MD Rousculp Journal of Diabetes and its Complications 21 (5), 306-314, 2007 | 202 | 2007 |
| Questionnaire to assess relevance and credibility of modeling studies for informing health care decision making: an ISPOR-AMCP-NPC Good Practice Task Force report JJ Caro, DM Eddy, H Kan, C Kaltz, B Patel, R Eldessouki, AH Briggs Value in health 17 (2), 174-182, 2014 | 191 | 2014 |
| Response to belimumab among patients with systemic lupus erythematosus in clinical practice settings: 24-month results from the OBSErve study in the USA CE Collins, M Dall'Era, H Kan, C Macahilig, C Molta, V Koscielny, ... Lupus Science & Medicine 3 (1), e000118, 2016 | 131 | 2016 |
| Burden of systemic lupus erythematosus on employment and work productivity: data from a large cohort in the southeastern United States C Drenkard, G Bao, G Dennis, HJ Kan, PM Jhingran, CT Molta, SS Lim Arthritis care & research 66 (6), 878-887, 2014 | 113 | 2014 |
| Comparison of metabolic syndrome incidence among schizophrenia patients treated with aripiprazole versus olanzapine or placebo. GJ L'Italien, DE Casey, HJ Kan, WH Carson, RN Marcus Journal of Clinical Psychiatry 68 (10), 1510-1516, 2007 | 93 | 2007 |
| Cumulative burden of oral corticosteroid adverse effects and the economic implications of corticosteroid use in patients with systemic lupus erythematosus M Shah, S Chaudhari, TP McLaughlin, HJ Kan, B Bechtel, GJ Dennis, ... Clinical therapeutics 35 (4), 486-497, 2013 | 82 | 2013 |
| Healthcare utilization and costs of systemic lupus erythematosus in Medicaid HJ Kan, X Song, BH Johnson, B Bechtel, D O'Sullivan, CT Molta BioMed research international 2013, 2013 | 72 | 2013 |
| Exploring the use of machine learning for risk adjustment: A comparison of standard and penalized linear regression models in predicting health care costs in older adults HJ Kan, H Kharrazi, HY Chang, D Bodycombe, K Lemke, JP Weiner PloS one 14 (3), e0213258, 2019 | 68 | 2019 |
| Comparison of Demographic Factors and Cardiovascular Risk Factor Control Among U.S. Adults with Type 2 Diabetes by Insulin Treatment Classification WND Wong K, Glovaci D, Malik S, Franklin SS, Wygant G, Iloeje U, Kan H Journal of Diabetes Complications 26 (3), 169-174, 2012 | 68* | 2012 |
| Presentation of SLE in UK primary care using the Clinical Practice Research Datalink AL Nightingale, JE Davidson, CT Molta, HJ Kan, NJ McHugh Lupus science & medicine 4 (1), e000172, 2017 | 59 | 2017 |
| Incidence and costs of treatment-related complications among patients with advanced squamous cell carcinoma of the head and neck K Lang, M Sussman, M Friedman, J Su, HJ Kan, D Mauro, E Tafesse, ... Archives of Otolaryngology–Head & Neck Surgery 135 (6), 582-588, 2009 | 50 | 2009 |
| Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model BK McEwan P, Evans M, Kan H Diabetes Obes Metab. 12 (5), 431-436, 2010 | 49 | 2010 |
| Burden of corticosteroid use in patients with systemic lupus erythematosus: results from a Delphi panel M Petri, B Bechtel, G Dennis, M Shah, T McLaughlin, H Kan, C Molta Lupus 23 (10), 1006-1013, 2014 | 44 | 2014 |
| Defining and assessing geriatric risk factors and associated health care utilization among older adults using claims and electronic health records HJ Kan, H Kharrazi, B Leff, C Boyd, A Davison, HY Chang, J Kimura, ... Medical care 56 (3), 233-239, 2018 | 43 | 2018 |
| Evaluating the impact of prescription fill rates on risk stratification model performance HY Chang, TM Richards, KM Shermock, SE Dalpoas, HJ Kan, ... Medical care 55 (12), 1052-1060, 2017 | 40 | 2017 |
| Predicted risk of diabetes and coronary heart disease in patients with schizophrenia: aripiprazole versus standard of care. L Blonde, HJ Kan, EM Gutterman, GJ L'Italien, MS Kim, L Hanssens, ... Journal of Clinical Psychiatry 69 (5), 741-748, 2008 | 39 | 2008 |
| Longitudinal treatment patterns and associated outcomes in patients with newly diagnosed systemic lupus erythematosus H Kan, S Nagar, J Patel, DJ Wallace, C Molta, DJ Chang Clinical therapeutics 38 (3), 610-624, 2016 | 36 | 2016 |
| Physician-patient interactions and outcomes in systemic lupus erythematosus (SLE): a conceptual model K Beusterien, JA Bell, J Grinspan, TO Utset, H Kan, S Narayanan Lupus 22 (10), 1038-1045, 2013 | 33 | 2013 |
